News

Filter

Current filters:

Granisetron

1 to 9 of 116 results

AP Pharma cuts workforce by 34%

29-05-2009

AP Pharma, a California, USA-based specialty drug firm, has implemented a reduction of about 34% in its…

GranisetronKytril

ProStrakan's 2008 revenue up 23%

30-03-2009

Scottish drugmaker Prostakan says that product sales in 2008 rose 32% on the year before to GBP53.8 million…

GranisetronGranisetron Transdermal SystemKytrilNystatinOralSancusoTestosteronetransdermal

Solasia's first drug trial initiated in Japan; China next

23-03-2009

Tokyo, Japan-based Solasia Pharma KK, a developer of western oncology pharmaceuticals in-licensed for…

GranisetronGranisetron Transdermal SystemKytrilSancusoTestosteronetransdermal

Japanese National Cancer Institute updates on generic drugs it has adopted

02-03-2009

The Central Hospital of Japan's National Cancer Center has disclosed the list of its adopted generic…

EisaiGranisetronKytril

Stock Commentary - Europe - week to Feb 16, 2009

23-02-2009

EUROPEAN: major bourses were down significantly in the reporting period to February 16, with investors…

AstraZenecaAventis PharmaGlaxoSmithKlineGranisetronGranisetron Transdermal SystemGSKKytrilNovartisPfizerSancusoSanofi-AventisWyeth

ProStrakan signs two Sancuso marketing deals

16-02-2009

Scottish drugmaker ProStrakan has signed two exclusive licence and supply agreements for certain countries…

GranisetronGranisetron Transdermal SystemKytrilNystatinOralSancuso

ProStrakan's Sancuso launched in USA

10-11-2008

Scottish drugmaker ProStrakan says that Sancuso (granisetron transdermal patch) has been launched in…

GranisetronGranisetron Transdermal SystemKytrilSancusoTestosteronetransdermal

1 to 9 of 116 results

Back to top